Examkin

Question

Difficulty: Very hardDiagnostic and Screening Test Performance

A public health task force is redesigning the diagnostic pathways for an emerging infectious disease. Match each proposed strategic or epidemiological adjustment on the left with its precise mathematical effect on diagnostic and screening test performance metrics on the right.

  • Lowering the quantitative threshold required for a positive result on a single continuous diagnostic biomarker.Decreases the false-negative rate of the assay by altering its positivity criterion, thereby increasing its intrinsic sensitivity and NPV while reducing its specificity.
  • Applying a screening assay exclusively to a high-risk symptomatic cohort rather than an unselected general population.Elevates the positive predictive value (PPV) solely by increasing the pre-test probability of the cohort, leaving the intrinsic sensitivity and specificity of the assay strictly unaffected.
  • Adopting an orthogonal serial testing algorithm (diagnosing disease only if an initial test AND a subsequent confirmatory test are both positive).Maximizes the net specificity and PPV of the diagnostic pathway by requiring concordant positive results across multiple independent assays, at the inherent cost of net sensitivity.
  • Adopting a simultaneous parallel testing algorithm (diagnosing disease if EITHER one of two distinct rapid tests is positive).Maximizes the net sensitivity and NPV of the diagnostic pathway by accepting any positive signal across multiple independent assays, at the inherent cost of net specificity.

Answer

Lowering thresholds increases intrinsic sensitivity and NPV; High-risk cohorts increase PPV without changing intrinsic metrics; Serial testing maximizes net specificity and PPV; Parallel testing maximizes net sensitivity and NPV.
Each strategic adjustment in diagnostic testing uniquely impacts performance metrics. Altering cutoffs trades sensitivity for specificity (or vice versa); changing the screened population alters predictive values based on Bayes' theorem without changing intrinsic test metrics; serial testing acts as a strict specificity filter; and parallel testing acts as a broad sensitivity net.

Step-by-Step Solution

1
Analyze the impact of a lowered cutoff threshold.
Lowering the cutoff makes the test more lenient, leading to decreased false negatives and increased false positives. This corresponds to increased sensitivity and NPV, but reduced specificity.
Understanding the intrinsic trade-off on a continuous receiver operating characteristic (ROC) curve.
2
Analyze the impact of altering the screening population.
Moving to a high-risk cohort increases the pre-test probability. This isolates the effect to the predictive values (increasing PPV, decreasing NPV) without altering intrinsic test characteristics.
Applying Bayes' theorem to population prevalence shifts.
3
Analyze the impact of an orthogonal serial testing algorithm.
Requiring multiple tests to be positive acts as a strict confirmation process, minimizing false positives. This maximizes overall specificity and PPV at the cost of sensitivity.
Understanding sequential probability and the mathematical effect of requiring concordant results.
4
Analyze the impact of a simultaneous parallel testing algorithm.
Accepting any positive result acts as a broad diagnostic net, minimizing false negatives. This maximizes overall sensitivity and NPV at the cost of specificity.
Understanding combined probability and the aggregation of false-positive risks.

Key Concept

The exact mathematical and clinical distinctions between altering continuous diagnostic cutoffs, shifting population pre-test probabilities, and implementing multi-test sequential (serial) versus simultaneous (parallel) diagnostic algorithms.
Rate this question

Topics

Diagnostic and Screening Test Performance

More questions from this topic